Elevated levels of IGF-1 may contribute to cancer risk by inhibiting apoptosis, stimulating cell proliferation and synthesis of sex steroids and inhibiting the synthesis of steroid hormone binding globulin [85, 89]. This evidence concerns the gene IGF1 and cancer.